Alfardan Medical with Northwestern Medicine Select Allscripts

AllscriptsAllscripts (NASDAQ: MDRX) announced that Alfardan Group, one of the leading family-owned conglomerates in Qatar and Chicago-based Northwestern Medicine have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine. The project is a part of Allscripts expansion in the Middle East and will provide ambulatory care services including Sunrise™ Ambulatory, Sunrise™ Surgery, Sunrise™ Radiology, Allscripts® Clinical Performance Management, Allscripts Lab™ and iPro Anesthesia™.

Based in Burj Alfardan, Lusail, Alfardan Medical with Northwestern Medicine is the first of Alfardan Group's investments in the health sector, as part of its social responsibility toward the State of Qatar and its vision to develop projects that will contribute to the realisation of the Qatar National Vision 2030. Alfardan Medical with Northwestern Medicine will offer high quality healthcare and a range of multidisciplinary medical specialisations in a unique clinical environment.

Used by healthcare organsations across the globe, Allscripts Sunrise is a fully integrated electronic health record that connects all aspects of care, including ambulatory, surgical, radiology, and laboratory services. Built to enable efficient and safe care, Sunrise is a physician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalised medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience for the consumer.

"Alfardan Group has built its reputation on offering our clients a lifestyle in keeping with the quality and premium services that they value," said Omar Hussain Alfardan, President and Chief Executive Officer of Alfardan Group. "We believe Allscripts is the suitable partner to help us deliver world-class integrated healthcare to Qatar."

"We are pleased to have the opportunity to partner with Alfardan Group and Northwestern Medicine in its new project," said Paul M. Black, Chief Executive Officer of Allscripts. "With the help of this new partnership in the Middle East, we can demonstrate the value of Allscripts commitment to open, connected communities of care to its people and across the globe."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

About Alfardan Medical with Northwestern Medicine (AMNM)

Alfardan Medical with Northwestern Medicine (AMNM) is an ambulatory care center that provides high quality, multidisciplinary medical specializations, based in Burj Alfardan, Lusail.

AMNM is an international collaboration between Alfardan Group and Northwestern Medicine (Chicago, U.S.A.). They each share a vision and a set of guiding values for the establishment, execution and operation of AMNM.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...